Racial Differences in Obesity-Related Risk Factors Between 2-Year-Old Children Born of Overweight Mothers

Bernard F Fuemmeler1, Marissa Stroo2, Chien-Ti Lee3

  • 1Department of Community and Family Medicine, Duke University Medical Center, bernard.fuemmeler@duke.edu.

Insights

Black children face more early-childhood obesity risk factors than White children, including diet and screen time, even after accounting for maternal weight and socioeconomic status.

Area of Science:

  • Pediatrics
  • Public Health
  • Sociology

Background:

  • Childhood obesity is a growing public health concern.
  • Socio-behavioral factors significantly influence obesity risk in early childhood.
  • Racial disparities in childhood obesity prevalence are well-documented.

Purpose of the Study:

  • To investigate racial differences in obesity-related socio-behavioral risk factors among young children.
  • To compare risk factors between Black and White children born to obese mothers.

Main Methods:

  • Surveyed 142 Black and 151 White 2-year-olds and their parents.
  • Assessed physical activity and food environments, parental role modeling, eating behaviors, feeding practices, child physical activity, and dietary intake.
  • Calculated body mass index (BMI) z-scores for children and BMI for parents.

Main Results:

  • Black families reported more obesity risk factors than White families in bivariate analyses.
  • Significant differences included greater soda availability, more television viewing, and poorer dietary intake in Black families.
  • Multivariate analyses confirmed significant differences in television watching and dietary intake between racial groups, even after adjusting for maternal BMI and socioeconomic factors.

Conclusions:

  • Black children and their families exhibit a higher number of obesity risk factors compared to White children.
  • These disparities persist after controlling for maternal body mass index and socioeconomic status.
  • Findings highlight the need for targeted interventions addressing socio-behavioral factors in at-risk populations.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
349
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
413
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.7K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
307